Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × HIV Infections × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

HIV Infections 1

Interventions

Doxorubicin 6 Vincristine 4 Liposomes 4 Bleomycin 4 Fluorouracil 3 Watchful Waiting 2 Light Coagulation 2 Imiquimod 2 sargramostim 1 Vaccines 1 Sodium Chloride 1 Papillomavirus Vaccines 1 Observation 1 Methotrexate 1 Leucovorin 1 Laser Therapy 1 Isotretinoin 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Dexamethasone 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Circumcision, Male 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03284866 2026-01-28

COVENANT

AIDS Malignancy Consortium

Phase 3 Completed

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡